ACET
ACET
NASDAQ · Biotechnology

Adicet Bio Inc

$7.78
-0.63 (-7.49%)
As of May 16, 2:17 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +86.9% upside
Low Target $12.76
Average Target $14.54
High Target $24.66
Current Price $7.78
Current
$7.78
Target
$14.54
$12.76 $14.54 avg $24.66
Scenario Analysis
Bear Case
$12.76
64.0%
Low target
Base Case
$14.54
+86.9%
Avg target
Bull Case
$24.66
+217.0%
High target
Risk/Reward
3.4x
Highly favorable
Price in Context
52-Week High
$17.44
-55.4% from high
52-Week Low
$6.01
+29.5% from low
Target vs 52W High
$14.54
-16.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%